The Value of Neutrophil Gelatinase-Associated Lipocalin Receptor as a Novel Partner of CD38 in Chronic Lymphocytic Leukemia: From an Adverse Prognostic Factor to a Potential Pharmacological Target?

Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of neoplastic B lymphocytes that escape death, and correlates with the expression of negative prognostic markers such as the CD38 antigen. Although certain new drugs approved by the US Food and Drug Administration improve the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauvois, Brigitte, Chapiro, Elise, Quiney, Claire, Maloum, Karim, Susin, Santos A., Nguyen-Khac, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525793/
https://www.ncbi.nlm.nih.gov/pubmed/37760777
http://dx.doi.org/10.3390/biomedicines11092335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525793/
https://www.ncbi.nlm.nih.gov/pubmed/37760777
http://dx.doi.org/10.3390/biomedicines11092335

Ejemplares similares